Ilaris 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FQWL0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,286
Award facts
- Contract value 100% obligated
- $29,286.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,286.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ILARIS 150 mg/ml vials. The delivery order was issued on January 13, 2026, with an ultimate completion date of February 4, 2026, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency designated as SPE2DR, established under the broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative—a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as a critical supplier within the military pharmaceutical supply chain, with an established track record of delivering diverse product portfolios including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as one of multiple regional prime vendor contractors authorized to issue firm fixed-price delivery orders supporting recurring medical supply needs of DoD healthcare operations globally. The current delivery order represents routine fulfillment of the company's established obligations under this strategic pharmaceutical supply contract.
Quick answers
Who was awarded contract SPE2DR26FQWL0?
SPE2DR26FQWL0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FQWL0 worth?
The government has obligated $29,286 on SPE2DR26FQWL0.
Is contract SPE2DR26FQWL0 an order under another contract?
Yes. SPE2DR26FQWL0 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWL0 competed?
The extent of competition for SPE2DR26FQWL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award